16 Director Compensation Table 2021 Name Fees earned or paid in cash ($) Option awards (1)(2) ($) Total ($) Richard Batycky, Ph.D. .............................. 41,717 17,731 59,448 Todd Bazemore........................................... 43,698 17,731 61,429 Christopher Cabell, M.D............................. 35,147 17,731 52,878 Michael J. Higgins ...................................... 80,000 29,552 109,552 Anand Varadan (3) ..................................... 14,250 21,241 35,491 Mark Iwicki(4)............................................ 23,967 17,731 41,698 Amit D. Munshi(5) ..................................... 12,008 17,731 29,739 (1) In accordance with SEC rules, this column reflects the aggregate fair value of option awards granted during the fiscal year ended December 31, 2021, computed as of their respective grant dates in accordance with Financial Accounting Standard Board Accounting Standards Codification Topic 718 for share-based compensation transactions. The assumptions made in the valuation of the share-based payments are contained in Note 10 to our consolidated financial statements for the fiscal year ended December 31, 2021 in our Annual Report on Form 10-K, for the year ended December 31, 2021. (2) As of December 31, 2021, our non-employee directors held the following aggregate number of options to purchase shares of our common stock: Dr. Batycky, 2,750 options; Mr. Bazemore, 2,250 options; Dr. Cabell, 2,250 options; Mr. Higgins, 4,874 options; Mr. Varadan, 1,500 options; Mr. Iwicki, 3,914 options; and Mr. Munshi, 3,414 options. (3) Mr. Varadan joined the Board on July 26, 2021. (4) Mr. Iwicki resigned from the Board on July 23, 2021. (5) Mr. Munshi resigned from the Board on April 2, 2021.
RkJQdWJsaXNoZXIy NTIzOTM0